Apixaban for preventing stroke and systemic embolism in people with nonvalvular atrial fibrillation

NICE technology appraisals [TA275] Published date:

NICE recommends apixaban as a possible treatment to prevent stroke and systemic embolism in some people with atrial fibrillation without underlying heart valve disease (see below).

Who can have apixaban ?

You should be able to have apixaban if 1 or more of the following apply:

  • you have had a stroke or transient ischaemic attack (mini stroke) in the past
  • you are 75 or older
  • you have high blood pressure
  • you have diabetes
  • you have heart failure with symptoms.

Why has NICE said this ?

NICE looks at how well treatments work, and also at how well they work in relation to how much they cost the NHS. NICE recommended apixaban as a treatment option because it works as well as other treatments available on the NHS. Although it also costs more than some other treatments, this was justified by the benefits it provided.

Get involved